The rate of twinning is rising and since the introduction of non-invasive prenatal testing, interest in and uptake of genetic screening and testing in twin pregnancies has not been investigated. This study aimed to explore the attitudes toward and uptake of current prenatal genetic screening and diagnostic testing options for fetal aneuploidy in twin pregnancies. Women being seen for genetic counseling with twin gestations were recruited for participation in a descriptive study with questionnaire (n = 42) and semi-structured phone interview (n = 15). Women were significantly more in favor of screening than diagnostic testing (p = 0.049). Sixty-nine (n = 25) percent elected screening, while one participant had a diagnostic procedure. Women were interested in screening for preparation or reassurance despite having concerns about accuracy and uncertainty. Most women (86%) felt they would make the same decision in a singleton pregnancy. Despite this, 48% cited twin pregnancy as influential to some degree. Information learned from providers, past experiences, and family and friends were also cited as influencing and anchoring factors, suggesting that tailoring prenatal genetic counseling sessions for twins might parallel that of singletons. No significant differences between natural and assisted conception patients were found. Although it did not alter patient decisions, genetic counseling was used as a platform to raise concerns and gather information.
Introduction
According to data from the US Department of Health and Human Services, the twin birth rate was 33.9 per 1000 births in 2014. This rate rose 76% from 1980 to 2009 and then rose an additional 2 % by 2013. Increasing twin birth rates have been associated with trends of delayed age at childbirth and increased use and availability of infertility treatments compared to previous decades (Hamilton et al. 2015) . Due to the association of delayed childbirth with increasing rate of twin pregnancies, genetic counselors may become involved in the prenatal care of women carrying twins for advanced maternal age (AMA) among other indications. AMA is a common referral for prenatal genetic counseling in the USA and is defined as a woman who will be 35 years or older at the time of delivery in a singleton pregnancy (ACOG practice bulletin 2016). However, many clinicians use 31 or 33 years or older as AMA for twin pregnancies due to the comparable risk for aneuploidy in at least one fetus (Meyers et al. 1997) .
The American Society for Reproductive Medicine (ASRM) defines assisted reproductive technology (ART) as treatments and procedures involving the handling of human oocytes and sperm, or embryos, with the intent of establishing pregnancy (Practice Committee of the Society for Assisted Reproductive & the American Society for Reproductive 2004) . Women who undergo ART procedures are more likely to have multiple gestations than women who conceive naturally. ART has been used in the USA since 1981, and today 1.6% of all infants born are conceived using ART (Centers for Disease Control and Prevention [CDC] 2015) . The psychosocial impact of infertility and ART has been linked to distress, loss of control, stigmatization, and a feeling of disruption in the way women viewed their life (Cousineau and Domar 2007) . Some stressors experienced include infertility itself, inconvenience associated with treatment, perception of a low success rate, time spent waiting for results, as well as financial pressure (Sanders and Bruce 1999) .
Whether conceived naturally or through ART, once women achieve a pregnancy, they are faced with decisions about screening and testing. Genetic counselors often act as facilitators for decision-making about prenatal genetic screening, such as first trimester screening, quadruple screening, or non-invasive prenatal testing (NIPT), and diagnostic testing. This is complicated in twin pregnancies because there is relatively little literature on aneuploidy screening in twin pregnancies and conclusions are inconsistent. Detection rates for Down syndrome when using first trimester nuchal translucency (NT) measurement, maternal age, and biochemical markers are 70-88% in twin pregnancies, which is similar to that in singleton pregnancies (Matias et al. 2005) . The Down syndrome detection rate of a quadruple marker serum screen is 51-63% (Gagnon and Audibert 2014) compared to 81% in singleton pregnancies (Malone et al. 2005 ). Results of screening tests are further complicated by not knowing which twin is at risk. Diagnostic testing via chorionic villus sampling (CVS) and amniocentesis is also available with no compromise in accuracy compared to singleton pregnancies. The risks with CVS appear to be relatively comparable between singletons and twins. Historically, the risk for miscarriage after amniocentesis appeared higher for twin gestations compared to singletons (Cahill et al. 2009 ). However, more recent studies suggest that this may no longer be the case (Lenis-Cordoba et al. 2013) .
In 2011, NIPT became clinically available, providing another prenatal screening option for high-risk pregnancies. NIPT using massively parallel shotgun sequencing (MPSS) technology can be applied to twin gestations and screens for trisomy 21, trisomy 18, trisomy 13, and the presence of the Y chromosome for fetal sex. While detection rate varies by testing laboratory, a meta-analysis in 2016 found a detection rate of 89.4% for trisomy 21 in twin pregnancies (Taylor-Phillips et al. 2016) .
Prior to the availability of NIPT as a screening option, a studied cohort of 343 twins ascertained for the Western Reserve Reading Project across Ohio, Kentucky, and Pennsylvania found that a minority (23%) of parents elected to undergo prenatal genetic screening or testing (Peters et al. 2006) . The authors found that 94% of the patients who did have prenatal genetic screening or testing chose maternal serum screening. It was hypothesized that it may be viewed as less risky than the alternatives while still relieving some anxiety. Furthermore, additional studies did not find a relationship between the use of ovulation induction (OI) or ART and election of prenatal genetic testing (Holmes and Jauniaux 2004; Peters et al. 2006 ). However, this study predates NIPT, a screen with higher sensitivity and specificity that might impact uptake. In addition, only a small percentage (8%) of Peters' participants recalled seeing a genetic counselor. Therefore, this study aimed to explore the uptake of and attitudes toward current prenatal genetic screening and testing options in twin pregnancies seen for genetic counseling in order to provide insight into the factors that play a role in the choice of whether to undergo genetic screening or testing.
Materials and Methods

Study Design
Women having genetic counseling at one of six McGovern Medical School at UTHealth, Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Maternal Fetal Medicine affiliated clinics or one of seven Baylor College of Medicine, Department of Obstetrics and Gynecology affiliated high-risk pregnancy clinics in the greater Houston area were recruited between August 2016 and January 2017. Eligible women included those who were pregnant with twins, age 18 or older, and English speaking who were seen for prenatal genetic counseling in their current pregnancy. Exclusion criteria included women under the age of 18, singleton pregnancies, non-English speakers, and twin pregnancies seen in the high-risk fetal center with anomalies excluded at the discretion of the genetic counselor. Participants were counseled for approximately 45 min by UTHealth and Baylor certified genetic counselors with Masters level training. In total, there were 40 eligible women at Baylor and 37 eligible women at UTHealth during the recruitment time period.
Eligible women were given a letter of invitation by the genetic counselor at the conclusion of the genetic counseling appointment. Participants could consent to either the anonymous survey only or the anonymous survey and an additional phone interview. Semi-structured interviews were conducted by the study coordinator (KR) via telephone with participants who indicated interest and provided contact information. Transcription by the interviewer was performed by listening to recorded audiotapes and transcribing everything spoken by the interviewer and study participant into a protected document.
The institutional review boards at the University of Texas Health Science Center at Houston (HSC-MS-16-0410) and Baylor College of Medicine (H-39711) approved the study protocol.
Data Collection
Data were collected through in person questionnaires collected immediately following the genetic counseling appointment and via semi-structured telephone interviews within 8 weeks of the appointment. The survey collected information about attitudes toward prenatal genetic screening and testing, changes in attitude or uptake related to the genetic counseling appointment, and impact of twin pregnancy on decision-making. Demographic information including age, gravidity and parity, indication for genetic counseling, use of ART, genetic screening/testing offered, and genetic screening/testing accepted was recorded by the genetic counselor (see Appendix 1). The telephone interviews were conducted by the study coordinator (KR) using an interview guide and lasted approximately 20 min. The telephone interviews were audiotaped and transcribed by the interviewer. The study questionnaire and interview guide were created by the authors and were not formally validated.
Data Analysis
Questionnaire data were entered into a secure Microsoft Excel file and STATA software version 13.1 was used for statistical analysis of quantitative data. Categorical variable data were reported as frequencies and percentages and analyzed using two-sample t test and Fischer's exact test. Transcripts were entered into ATLAS.ti version 1.0.50. Thematic analysis was used to identify major themes in the responses. Each transcript was coded and grouped into categories that revealed similar themes. The study coordinator (KR) and one author (CS) independently analyzed three transcripts to compare and establish consistency in coding using a preliminary codebook. An inter-coder concordance of 80% was achieved. KR analyzed the remaining transcripts and grouped responses into themes.
Results
A total of 42 individuals participated in the study. Of those, 27 (64%) consented to participate in the phone interview in addition to the questionnaire, while 15 (36%) consented to the questionnaire only. Of the 27 who indicated willingness to participate in the phone interview portion, there were 16 (59%) individuals who completed the interview and 11 (41%) who could not be reached after multiple attempts. One completed interview was excluded from analysis due to fragmented recording. The average age of study participants was 31 years, with a range from 21 to 47 years old, and the majority (45%) was Caucasian ( Table 1 ). The majority of participants were multigravida (69%) with the most common indications being AMA (43%) and low risk (38%). Eleven participants were from UTHealth clinics and 31 were from Baylor clinics, representing 30% of eligible UTHealth patients (11/37) and 78% of eligible Baylor patients (31/40) seen for prenatal genetic counseling during the survey collection period. No significant differences in demographic distribution were found between participants from the UTHealth and Baylor sites (p > 0.05), (Table 1) . Additionally, demographic distribution of the study sample was not significantly different between those who were interviewed and those that only answered the questionnaire (p > 0.05), (Table 1) .
Attitude Toward Prenatal Genetic Screening and Testing
Participants were found to be significantly more likely to be Bin favor of^or Bstrongly in favor of^prenatal genetic screening compared to prenatal diagnostic testing (p = 0.049), (Fig. 1) .
Comparing attitudes of those with a natural conception to those with assisted conception revealed no significant difference between the groups (p > 0.05). In general, both groups were more in favor of screening than diagnostic testing, with 80% of those with a natural conception and 92% of those with assisted conception feeling Bin favor of^or Bstrongly in favor of^prenatal genetic screening. Indication for genetic counseling referral was not found to have a significant influence on attitude toward prenatal genetic screening or testing (p > 0.05 across indications).
Interest in Prenatal Genetic Screening and/or Testing
Interview respondents reported an overall general interest in prenatal genetic screening and/or testing. Motivations for this interest varied among responses, with the risk of possible abnormalities in the pregnancy being the most commonly used code. One woman indicated B[she's] always scared that [the test] will come back that…[their] risk is higher for somethingb ut that Bit's always better to know.T he next most common motivation for interest in prenatal genetic testing was a desire for answers in order to be better prepared, reassured, or have peace of mind. Forty-eight percent of participants selected gaining reassurance about the pregnancy as an influencing factor in the questionnaire. Participants felt that Bit's one of those things where [they] would like to be prepared if something was to happen^and that Bwith twins… [they] need to know what's going on as much as possible.^Additional examples of interest in prenatal genetic screening and/or testing can be found in Table 2 .
Concerns About Prenatal Genetic Screening and/or Testing
Respondents also expressed concerns about prenatal genetic screening and/or testing. In some cases, these concerns were strong enough to make the woman not interested in screening or testing. The most common concern was for the risks posed to the pregnancy as one woman expressed in her statement BI would've rather not taken that risk of losing them than trying to figure out if something was wrong with them.^An interview with a woman who conceived via IVF revealed substantial concern about invasive testing due to associated risks. She said that she felt she Bworried more about loss… than if [conception] had happened easily^and that she knew Bit's not going to be easy… if [they] needed to start over.Â dditional concerns included financial cost, anxiety, uncertainty, and accuracy of screening (Table 3) .
Overall, codes associated with concern about prenatal genetic screening and/or testing were used more frequently (n = 171) than codes associated with interest in prenatal genetic screening and/or testing (n = 99).
Factors Influencing Decision-Making
Respondents indicated that information gathering was an important factor in decision-making (n = 46) both from information they learned in the genetic counseling session and outside of the session. For example, one woman said that Bif anything, [the genetic counselor] gave [them] information to actually formulate opinions.Ê xperiences in previous pregnancies and experiences of friends and family members were cited as influencing factors (n = 37). One woman said, Bit's one of those things… [they have] historically done just the… standard first trimester screen.^Additionally, input of support persons such as partners or spouses played a role in women's decision-making. One woman said that she and her husband Bweighed out the pros and cons^and that he B… invasive stuff comes with risks…I definitely didn't really want to do those unless there was…a high, high risk of some abnormalitiesB … but as far as the other options, [first trimester screening] felt like safer, like a safer optionB I would've rather not taken that risk on losing them than trying to figure out if something was wrong with themF ear and anxiety (n = 18)
BI had a lot of anxiety about the pregnancy as it is… testing is… another thing to be anxious about.B I was actually pretty scared and nervous.F inancial cost (n = 16) B… with the cost involved, I have done it even for one [baby]B I had some friends say no don't do it it's kind of a waste of money.B
But it wasn't covered by my insurance and I'm already paying a lotB
If money wasn't something that was obviously sitting there staring me right in the face… we would have absolutely gone ahead with the genetic testing.Ĉ oncern about accuracy (n = 10)
B… it sounds like the accuracy is higher with just one baby than it is with two. So I think then we might have been more willing to do itB …if there was only one we might have been more open to it but since there was two… and the accuracy is not as high, we were less inclinedÛ ncertainty (n = 9) BI think with fraternal, I'd always wonder… which twin it came from and…worry about it that wayB … we didn't know really what the sort of accuracy rates were… or many of the specifics of… how the information, how the results are deliveredT anting answers (n = 9) B… is there a way for us to find out if we're going to have a healthy baby or if both babies are going to be healthy? Then we want to go ahead and do a prescreening.P reparation (n = 7) BI think it's important to know everything you can before going into itR eassurance (n = 6) BI would have done it anyways just to kind of make sure there weren't any problemsB I just wanted to make sure there wasn't anything that I need to be worried about as far as like you know the health of the babyP eace of mind (n = 3) B[genetic testing] does have such an ability to bring peace of mind or to… help parents…plan… get a better idea of what…they're walking intoÂ ttitudes Toward and Uptake of Prenatal Genetic Screening and Testing in Twin Pregnancies was a Bmajor factor in it… and helped decide if [they] were going to do it or not.^Two of the most common factors selected in the questionnaire as having influenced participants' decisions included being pregnant with twins (48%) and their partner/spouse (43%). Additional examples of factors influencing decision-making can be found in Table 4 .
Uptake of Prenatal Genetic Screening and Testing
There was no significant difference in uptake of prenatal genetic screening and testing between natural and assisted conception women (p = 0.48). When asked about whether or not their decision about prenatal genetic screening or testing was consistent with their feelings prior to the genetic counseling appointment, 91% answered that it was. Additionally, 86% of women answered that their decision about prenatal genetic screening and testing would have been the same if it were a singleton pregnancy. Of the 41 women offered a prenatal genetic screening or diagnostic test, 37% declined all testing. Of the 36 women offered prenatal genetic screening (first trimester screen, quadruple screen, NIPT), 69% accepted. Of the 39 women offered diagnostic genetic testing (chorionic villus sampling, amniocentesis), one individual (3%) accepted (Fig. 2) . Individuals who accepted a screening test had attitudes that were generally more Bstrongly in favor ofT I would say that the only thing that the counselor kind of affected for was like looking at those charts and seeing… the percentage of risk based on the ageB … she broke everything down, you know, and explained… all of our optionsP rior experience and knowledge (n = 37)
B… the test that we chose and doing that with my last son, him being perfectly fine then I was pretty much at ease with doing the same testB … my cousin got the [amniocentesis]… she wanted to know and she ended up losing her kids cause of the infectionB I was seen by the same doctor with… all my three children… But I was never offered… so I didn't even know you had those kind of testingŜ upport persons (n = 3) B… my husband. I asked him what he thought and he said yeah let's just do the same test we did with my sonB … my mom… went with me… she was the one who… guided me in the decision making process.B … my mom said that she never got any of that testing done but I just don't think it was available at the time. Fig. 2 Uptake of prenatal genetic screening and diagnostic testing screening (56%) compared to those that declined screening (18%); however, the overall difference in attitudes was not significant (p = 0.053). Those who accepted a prenatal genetic screening test were significantly more likely to say that they would make the same decision if it were a singleton pregnancy (p = 0.030), (Fig. 3) . All four of the women who indicated that they would make a different decision about prenatal genetic screening or testing in the pregnancy if it were a singleton were also a part of the 48% of women who selected being pregnant with twins as having influenced decisions.
Discussion
To our knowledge, this is the first study exploring the attitudes toward and uptake of prenatal genetic screening and testing in twin gestations since the availability of NIPT that expanded options for many women. As anticipated from increasing trends toward uptake of screening rather than invasive testing in singleton pregnancies since the introduction of NIPT, we found that women carrying twins were more likely to be in favor of prenatal genetic screening compared to diagnostic testing (Friel et al. 2014) . The risk of diagnostic testing appeared to be a deterrent for some, as seen in previous studies (Allyse et al. 2014) . Of note, participants were quoted a 1/100-1/200 procedure related risk for CVS and up to a 1/50-1/100 procedure related risk for amniocentesis with a twin gestation. Women communicated a desire to have answers to be better prepared or for reassurance. Interview responses revealed varying levels of reassurance felt based on screening alone. Attitudes did not differ depending on whether women conceived twin pregnancies naturally or through assisted conception methods. Despite participants being in favor of screening, concerns and barriers were more frequently discussed than interest. Genetic counseling was used as a platform to relay these concerns and gather additional information about screening and testing, empowering women to make a decision. It appears as though the genetic counseling process made women feel more comfortable with their decision rather than altering it, although future research is needed to capture both pre-and post-counseling feelings in order to confirm this finding.
Over half of our cohort elected screening or testing; by comparison, 23% of a 2006 cohort of 343 twin or higher or multiple pregnancies elected screening or testing (Peters et al. 2006) . It is possible that this difference can be explained by the advancements in maternal serum screening, including first trimester nuchal translucency measurements, and the availability of NIPT. The higher detection rate and lower false positive rate compared to older screens may have lessened concerns. Given that detection rates of screening tests are even higher in singletons, those who elected to undergo screening might have done so regardless of twin gestation. In fact, the majority of women said they would make the same decision if they had a singleton pregnancy, suggesting that having twins was not a strong influencing factor. In contradiction, Bbeing pregnant with twins^was the most commonly cited factor influencing participants' decision-making from the questionnaire. Perhaps the strength of these factors differs among individuals. As a genetic counselor, it is therefore necessary to uncover which factors in a patient's life have the strongest influence in decision-making. Understandably, the few women who indicated that they would make a different decision about prenatal genetic screening or testing in the pregnancy if it were a singleton were all a part of the 48% who selected being pregnant with twins as having influenced decisions. Genetic counselors have the skill set to uncover which women are concerned about the complexity of screening and testing in a twin pregnancy, to encourage discussion, and to assist in decision-making.
The process of genetic counseling did not appear to ultimately alter decisions about prenatal genetic screening and testing for most women, although interview responses indicated that patients do find genetic counseling helpful and informative. Information gathering about genetic screening and testing takes place in multiple settings, including medical appointments, past personal experience, and through the experiences of family and friends. Genetic counseling seeks to not only provide information but also to explore the values and beliefs that play an important role in informed decisionmaking for the patient. It is possible that anchoring, the concept that people's decisions are most influenced by their initial experiences and knowledge, can explain why the majority of women reported that genetic counseling did not change their initial impression of genetic screening and testing (Tversky and Kahneman 1974) . The anchoring heuristic has been previously explored in genetic counseling decision-making, with positive attitude toward genetic testing being one of the determining factors predicting intent to undergo testing (Pivetti and Melotti 2013) . While patients say they are open to learning more information, anchors appear to play an important role in shaping their perspective in prenatal genetic counseling.
Practice Implications
This study provides insight into the attitudes toward prenatal genetic screening and testing in women carrying twin pregnancies in an effort to assist in the tailoring of sessions for this patient population. Data suggest conducting sessions for twin gestations might parallel that of singletons. Anticipating concerns about risks, financial cost, uncertainty, and accuracy surrounding testing options might make facilitation of decisionmaking easier and uncover those patients for whom the complexity of multiples alters their decision. However, genetic counseling is not likely to change the majority of patient's attitudes set by personal anchors. Instead, genetic counseling provides a platform to explore information with respect to the patient's position and ultimately assists in informed decisionmaking that often aligns with their original anchors.
Study Limitations
The small sample size was a major limitation of the current study, as this impacted the ability to make comparisons between those with natural and assisted conceptions in the interview portion. A longer recruitment time frame might increase sample size enough to increase the power to uncover statistically significant differences. The study questionnaire and interview guide were created by the authors and were not formally validated and therefore did not prompt exploration into all topics. Another limitation was the limited demographic information collected, as the influence of socioeconomic status, education level, or religious affiliation on decision-making could not be explored. Additionally, gestational age was not collected; therefore, we cannot comment on the relationship between gestational age and decision-making. Of note, the interviews did not take place at the same duration after the genetic counseling appointment for all participants. Some individuals could not be reached for over a month, and it is possible that the length of time since the genetic counseling appointment altered their attitude and responses. In addition, participants who had stronger attitudes toward prenatal genetic screening and testing may have felt compelled to share their perspectives and thus led to an ascertainment bias.
Research Recommendations
Additional studies with larger cohorts should be undertaken in order to determine if there are in fact differences between the natural and assisted conception groups that were not uncovered by the current study. Surveying a cohort that spanned all regions of the country could provide more comprehensive data on the uptake of screening versus diagnostic testing in twin gestations. Furthermore, surveying women's attitudes both pre-and post-conception, pre-and post-genetic counseling, or including a singleton matched comparison group could provide more insight into potential differences.
Conclusion
The majority of women with twin gestations was in favor of and opted into prenatal genetic screening, despite expressing some concerns. Most did not feel that their decision would vary if they had been carrying a singleton, suggesting conducting genetic counseling for twin gestations might be similar to that of singletons. Genetic counselors have the skill set to uncover which women belong to the minority who are concerned about the complexity of testing in twins and to assist in decision-making. Although it did not alter patient decisions, genetic counseling provides a platform to raise concerns and gather information.
